Costs of illness and care in Parkinson's disease:an evaluation in six countries

von Campenhausen, Sonja and Winter, Yaroslav and Rodrigues e Silva, Antonio and Sampaio, Christina and Ruzicka, Evzen and Barone, Paolo and Poewe, Werner and Guekht, Alla and Mateus, Ceu and Pfeiffer, Karl-P. and Berger, Karin and Skoupa, Jana and Bötzel, Kai and Geiger-Gritsch, Sabine and Siebert, Uwe and Balzer-Geldsetzer, Monika and Oertel, Wolfgang H. and Dodel, Richard and Reese, Jens P. (2011) Costs of illness and care in Parkinson's disease:an evaluation in six countries. European Neuropsychopharmacology, 21 (2). pp. 180-191. ISSN 0924-977X

Full text not available from this repository.

Abstract

We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.

Item Type:
Journal Article
Journal or Publication Title:
European Neuropsychopharmacology
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/2800/2808
Subjects:
ID Code:
75888
Deposited By:
Deposited On:
21 Oct 2015 05:01
Refereed?:
Yes
Published?:
Published
Last Modified:
27 Oct 2020 05:10